This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow This Policy is No Longer Valid.
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rennels, M. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Rennels, M. B.
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Influenza
PEDIATRICS Vol. 110 No. 6 December 2002, pp. e80-e80

ELECTRONIC ARTICLE

Technical Report: Reduction of the Influenza Burden in Children

Epidemiologic studies have shown that children of all ages with certain chronic conditions, such as asthma, and otherwise healthy children younger than 24 months (6 through 23 months) are hospitalized for influenza and its complications at high rates similar to those experienced by the elderly. Annual influenza immunization is already recommended for all children 6 months and older with high-risk conditions. By contrast, influenza immunization has not been recommended for healthy young children. To protect children against the complications of influenza, increased efforts are needed to identify and recall high-risk children. In addition, immunization of children between 6 through 23 months of age and their close contacts is now encouraged to the extent feasible. Children younger than 6 months may be protected by immunization of their household contacts and out-of-home caregivers. The ultimate goal is universal immunization of children 6 to 24 months of age. Issues that need to be addressed before institution of routine immunization of healthy young children include education of physicians and parents about the morbidity caused by influenza, adequate vaccine supply, and appropriate reimbursement of practitioners for influenza immunization. This report contains a summary of the influenza virus, protective immunity, disease burden in children, diagnosis, vaccines, and antiviral agents.

Margaret B. Rennels, MD, H. Cody Meissner, MD and Committee on Infectious Diseases

Key Words: influenza • vaccine • treatment • diagnosis • antiviral

Abbreviations: HA, hemagglutinin • NA, neuraminidase • IgA, immunoglobulin A • HAI, hemagglutinin-inhibiting • AOM, acute otitis media • CDC, Centers for Disease Control and Prevention • PCR, polymerase chain reaction • TIV, trivalent inactivated influenza vaccine • T-CAIV, trivalent live-attenuated, cold-adapted influenza vaccine • FDA, Food and Drug Administration • GBS, Guillain-Barré syndrome • CI, confidence interval • HIV, human immunodeficiency virus • MMR, measles-mumps-rubella • NIH, National Institutes of Health • TCID, tissue culture infectivity dose




This article has been cited by other articles:


Home page
 CVIHome page
B. D. Forrest, M. W. Pride, A. J. Dunning, M. R. Z. Capeding, T. Chotpitayasunondh, J. S. Tam, R. Rappaport, J. H. Eldridge, and W. C. Gruber
Correlation of Cellular Immune Responses with Protection against Culture-Confirmed Influenza Virus in Young Children
Clin. Vaccine Immunol., July 1, 2008; 15(7): 1042 - 1053.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
T. Baas, C. R. Baskin, D. L. Diamond, A. Garcia-Sastre, H. Bielefeldt-Ohmann, T. M. Tumpey, M. J. Thomas, V. S. Carter, T. H. Teal, N. Van Hoeven, et al.
Integrated Molecular Signature of Disease: Analysis of Influenza Virus-Infected Macaques through Functional Genomics and Proteomics
J. Virol., November 1, 2006; 80(21): 10813 - 10828.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
S. J. Hambidge, J. M. Glanz, E. K. France, D. McClure, S. Xu, K. Yamasaki, L. Jackson, J. P. Mullooly, K. M. Zangwill, S. M. Marcy, et al.
Safety of Trivalent Inactivated Influenza Vaccine in Children 6 to 23 Months Old
JAMA, October 25, 2006; 296(16): 1990 - 1997.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
S S S Teo, J S Nguyen-Van-Tam, and R Booy
Influenza burden of illness, diagnosis, treatment, and prevention: what is the evidence in children and where are the gaps?
Arch. Dis. Child., May 1, 2005; 90(5): 532 - 536.
[Abstract] [Full Text] [PDF]

Home page
 AAP NewsHome page
H. C. Meissner
Interim recommendations address use of antivirals, administration of vaccine
AAP News, December 1, 2004; 25(6): 279 - 293.
[Full Text] [PDF]